JNJ

bullish · high conviction track record →

Johnson & Johnson Eyes Double-Digit Revenue Growth

Watch: Monitor April 14 earnings for details on innovative medicine growth and pipeline commercialization impacts.

Full analysis

JNJ's stock surged 18.74% in Q1 2026 to $238.46, led by strong growth in oncology and immunology within the Innovative Medicine segment. FDA approvals of ICOTYDE and TECVAYLI combo expand blockbuster pipeline, supporting expected double-digit revenue growth by decade end. Despite $127 million insider sell-off, diversified institutional holders and positive analyst sentiment remain intact.

The company’s robust drug pipeline and strong segment growth underpin a bullish outlook, outweighing insider selling and driving confidence in sustained revenue acceleration.

Compare

vs NVDA vs AMD vs AAPL vs TSLA vs MSFT vs META vs GOOGL vs AMZN vs TSM vs ASML

Evidence

55m ago Wells Fargo main JNJ: Overweight → Overweight
21h ago Is This Dividend King With a 63-Year Dividend Streak A Buy Before April 14? yahoo-finance
1d ago Jim Cramer on Johnson & Johnson: “If It Gets Blasted, Try to Get Some” yahoo-finance
1d ago Earnings live updates: Johnson & Johnson Q1 profit beats estimates, BlackRock touts strong start to year yahoo-finance
1d ago Insider buy by WOODS EUGENE A (JNJ): $14,553
1d ago Insider sell by SWANSON JAMES D (JNJ): $15,109,759
1d ago Insider sell by WOLK JOSEPH J (JNJ): $21,767,827
1d ago Insider sell by REED JOHN C (JNJ): $13,105,233
7 older signals
1d ago Insider sell by DUATO JOAQUIN BOIX (JNJ): $22,122,893
1d ago Insider buy by MORIKIS JOHN G (JNJ): $257,688
1d ago Insider sell by TAUBERT JENNIFER L (JNJ): $10,040,883
1d ago Insider sell by DUATO JOAQUIN BOIX (JNJ): $22,548,655
1d ago Insider buy by WEINBERGER MARK A (JNJ): $147,220
2d ago Johnson & Johnson (JNJ) is Gaining from Its Strong Innovative Medicine Growth
4d ago The $100 Billion Pivot: Why Johnson & Johnson Is My Top Dividend King to Buy in 2026
15 signals · latest 55m ago

Get alerted when JNJ changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →